✦ LIBER ✦

PCN24 ECONOMIC EVALUATION OF SORAFENIB VERSUS BEST SUPPORTIVE CARE IN ADVANCED RENAL CELL CARCINOMA: AN UPDATED COST-EFFECTIVENESS ANALYSIS

✍ Scribed by X Gao; S Shah; P Reddy; K Gondek; CL Pashos

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN16 COST-EFFECTIVENESS OF SORAFENIB VE

✍ P Maroto; H Villavicencio; C Piñol; L Urruticoechea 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PCN33 COST-EFFECTIVENESS ANALYSIS OF SOR

✍ V Teich; RA Fernandes; A Schiola 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PCN64 COST-EFFECTIVENESS ANALYSIS OF SOR

✍ N Muszbeck; U Munir; H Vioix; A Schiola; A Valderrama; V Teich 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCN68 COST-EFFECTIVENESS ANALYSIS OF SOR

✍ N Muszbeck; H Vioix; U Munir; A Schiola; A Valderrama; V Teich 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB